Axogen Q3 EPS $(0.07) Beats $(0.11) Estimate, Sales $28.6M Beat $28.31M Estimate

Axogen (NASDAQ:AXGN) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.11) by 36.36 percent. This is a 40 percent decrease over losses of $(0.05) per share from the same

Benzinga · 11/06/2019 22:08

Axogen (NASDAQ:AXGN) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.11) by 36.36 percent. This is a 40 percent decrease over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $28.6 million which beat the analyst consensus estimate of $28.31 million by 1.02 percent. This is a 26.21 percent increase over sales of $22.66 million the same period last year.